Teodor Svantesson http://orcid.org/0000-0003-1929-2288 Kim van Oudenaarde Bruno Fuchs Beata Bode Alexander Vogetseder

Abstract

Xanthogranulomatous epithelial tumor (XGET) is an extremely rare and recently described mesenchymal neoplasm characterized by a distinctive histological appearance and clinical presentation. This case report describes a unique case of XGET in a 66-year-old female patient who presented with a 5 cm mass in the dorsal distal left thigh. The clinical, radiological, and pathological findings, as well as the management and follow-up, are discussed.

##plugins.themes.bootstrap3.article.details##

Keywords

soft tissue, emerging entities, xanthogranulomatous inflammation, cytokeratin, uncertain biologic potential

References
1. Fritchie KJ, Torres-Mora J, Inwards C, et al. Xanthogranulomatous epithelial tumor: report of 6 cases of a novel, potentially deceptive lesion with a predilection for young women. Mod Pathol. 2020;33(10):1889-1895. doi: 10.1038/s41379-020-0562-8. PMID: 32415263.
2. Agaimy A, Michal M, Stoehr R, et al. Recurrent novel HMGA2-NCOR2 fusions characterize a subset of keratin-positive giant cell-rich soft tissue tumors. Mod Pathol. 2021;34(8):1507-1520. doi: 10.1038/s41379-021-00789-8. PMID: 33742141; PMCID: PMC8295036.
3. Brahmi M, Alberti L, Tirode F, et al. Complete response to CSF1R inhibitor in a translocation variant of teno-synovial giant cell tumor without genomic alteration of the CSF1 gene. Ann Oncol. 2018;29(6):1488-1489. doi: 10.1093/annonc/mdy129. PMID: 29668829.
4. Dehner CA, Baker JC, Bell R, et al. Xanthogranulomatous epithelial tumors and keratin-positive giant cell-rich soft tissue tumors: two aspects of a single entity with frequent HMGA2-NCOR2 fusions. Mod Pathol. 2022;35(11):1656-1666. doi: 10.1038/s41379-022-01115-6. PMID: 35690644.
5. Miettinen M, Limon J, Niezabitowski A, Lasota J. Patterns of keratin polypeptides in 110 biphasic, monophasic, and poorly differentiated synovial sarcomas. Virchows Arch. 2000;437(3):275-283. doi: 10.1007/s004280000238. PMID: 11037348.
6. Miettinen M, Fanburg-Smith JC, Virolainen M, Shmookler BM, Fetsch JF. Epithelioid sarcoma: an immunohistochemical analysis of 112 classical and variant cases and a discussion of the differential diagnosis. Hum Pathol. 1999;30(8):934-942. doi: 10.1016/s0046-8177(99)90247-2. PMID: 10452506.
7. Benassi MS, Campanacci L, Gamberi G, et al. Cytokeratin expression and distribution in adamantinoma of the long bones and osteofibrous dysplasia of tibia and fibula. An immunohistochemical study correlated to histogenesis. Histopathology. 1994;25(1):71-76. doi: 10.1111/j.1365-2559.1994.tb00600.x. PMID: 7525449.
8. Al-Abbadi MA, Almasri NM, Al-Quran S, Wilkinson EJ. Cytokeratin and epithelial membrane antigen expression in angiosarcomas: an immunohistochemical study of 33 cases. Arch Pathol Lab Med. 2007;131(2):288-292. doi: 10.5858/2007-131-288-CAEMAE. PMID: 17284115.
How to Cite
Xanthogranulomatous epithelial tumor: a novel entity of uncertain biologic potential. (2023). Archive of Clinical Cases, 10(3), Arch Clin Cases. 2023;10(3):142-145. https://doi.org/10.22551/2023.40.1003.10261
Section
Case Reports

How to Cite

Xanthogranulomatous epithelial tumor: a novel entity of uncertain biologic potential. (2023). Archive of Clinical Cases, 10(3), Arch Clin Cases. 2023;10(3):142-145. https://doi.org/10.22551/2023.40.1003.10261